Clinical Trial Update: A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of apatinib and docetaxel in locally advanced or metastatic gastric or GEJ adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Apatinib (apatinib)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Metastatic Gastric Adenocarcinoma | Phase 1 | Status: UNKNOWN